Literature DB >> 20564331

Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion.

Wei Ding1, Hanning You, Hien Dang, Francis LeBlanc, Vivian Galicia, Shelly C Lu, Bangyan Stiles, C Bart Rountree.   

Abstract

UNLABELLED: Epithelial-to-mesenchymal transition (EMT) is predicted to play a critical role in metastatic disease in hepatocellular carcinoma. In this study, we used a novel murine model of EMT to elucidate a mechanism of tumor progression and metastasis. A total of 2 x 10(6) liver cells isolated from Pten(loxp/loxp)/Alb-Cre(+) mice, expanded from a single CD133(+)CD45(-) cell clone, passage 0 (P0), were sequentially transplanted to obtain two passages of tumor cells, P1 and P2. Cells were analyzed for gene expression using microarray and real-time polymerase chain reaction. Functional analysis included cell proliferation, migration, and invasion in vitro and orthotopic tumor metastasis assays in vivo. Although P0, P1, and P2 each formed tumors consistent with mixed liver epithelium, within the P2 cells, two distinct cell types were clearly visible: cells with epithelial morphology similar to P0 cells and cells with fibroblastoid morphology. These P2 mesenchymal cells demonstrated increased locomotion on wound healing; increased cell invasion on Matrigel basement membrane; increased EMT-associated gene expression of Snail1, Zeb1, and Zeb2; and down-regulated E-cadherin. P2 mesenchymal cells demonstrated significantly faster tumor growth in vivo compared with P2 epithelial counterparts, with invasion of intestine, pancreas, spleen, and lymph nodes. Furthermore, P2 mesenchymal cells secreted high levels of hepatocyte growth factor (HGF), which we propose acts in a paracrine fashion to drive epithelial cells to undergo EMT. In addition, a second murine liver cancer stem cell line with methionine adenosyltransferase 1a deficiency acquired EMT after sequential transplantations, indicating that EMT was not restricted to Pten-deleted tumors.
CONCLUSION: EMT is associated with a high rate of liver tumor proliferation, invasion, and metastasis in vivo, which is driven by HGF secreted from mesenchymal tumor cells in a feed-forward mechanism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20564331      PMCID: PMC3032356          DOI: 10.1002/hep.23748

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  38 in total

1.  Hepatocellular carcinoma and cholangiocarcinoma are associated with high serum levels of hepatocyte growth factor.

Authors:  Yasemin H Balaban; Durdal Us; Gulsen Hascelik; Yusuf Bayraktar
Journal:  Indian J Gastroenterol       Date:  2006 Jul-Aug

Review 2.  Invasion assays.

Authors:  H K Kleinman; K Jacob
Journal:  Curr Protoc Cell Biol       Date:  2001-05

3.  Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice.

Authors:  Gakuhei Son; Tadamichi Hirano; Ekihiro Seki; Yuji Iimuro; Toshihiro Nukiwa; Kunio Matsumoto; Toshikazu Nakamura; Jiro Fujimoto
Journal:  J Hepatol       Date:  2006-05-30       Impact factor: 25.083

4.  Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.

Authors:  Christine L Chaffer; Janelle P Brennan; John L Slavin; Tony Blick; Erik W Thompson; Elizabeth D Williams
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

5.  Expression of hepatocyte growth factor in human hepatocellular carcinoma.

Authors:  J Guirouilh; B Le Bail; L Boussarie; C Balabaud; P Bioulac-Sage; A Desmoulière; D Schuppan; J Rosenbaum
Journal:  J Hepatol       Date:  2001-01       Impact factor: 25.083

6.  Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta.

Authors:  Hanning You; Wei Ding; C Bart Rountree
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

7.  SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma.

Authors:  Q Xie; K D Liu; M Y Hu; K Zhou
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

8.  Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma.

Authors:  R T Poon; I O Ng; C Lau; W C Yu; S T Fan; J Wong
Journal:  Am J Surg       Date:  2001-09       Impact factor: 2.565

9.  Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase.

Authors:  K Nakanishi; J Fujimoto; T Ueki; K Kishimoto; T Hashimoto-Tamaoki; J Furuyama; T Itoh; Y Sasaki; E Okamoto
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

10.  Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma.

Authors:  R F Niu; L Zhang; G M Xi; X Y Wei; Y Yang; Y R Shi; X S Hao
Journal:  J Exp Clin Cancer Res       Date:  2007-09
View more
  73 in total

1.  Impact of gestational low-protein intake on embryonic kidney microRNA expression and in nephron progenitor cells of the male fetus.

Authors:  Letícia de Barros Sene; Wellerson Rodrigo Scarano; Adriana Zapparoli; José Antônio Rocha Gontijo; Patrícia Aline Boer
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

2.  CXCL12/CXCR4 Axis Upregulates Twist to Induce EMT in Human Glioblastoma.

Authors:  Chengjun Yao; Panpan Li; Huishu Song; Fuxi Song; Yalan Qu; Xiaochen Ma; Ranran Shi; Jinsong Wu
Journal:  Mol Neurobiol       Date:  2015-07-16       Impact factor: 5.590

3.  Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug.

Authors:  Chun Sun; Lu Sun; Yan Li; Xiaonan Kang; Shu Zhang; Yinkun Liu
Journal:  Med Oncol       Date:  2013-02-21       Impact factor: 3.064

4.  MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.

Authors:  Wei-Dong Lu; Yun Zuo; Zhen Xu; Min Zhang
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

5.  Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Takahiro Kodama; Justin Y Newberg; Michiko Kodama; Roberto Rangel; Kosuke Yoshihara; Jean C Tien; Pamela H Parsons; Hao Wu; Milton J Finegold; Neal G Copeland; Nancy A Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

6.  c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma.

Authors:  Hanning You; Wei Ding; Hien Dang; Yixing Jiang; C Bart Rountree
Journal:  Hepatology       Date:  2011-07-19       Impact factor: 17.425

7.  Strong expression of CD133 is associated with increased cholangiocarcinoma progression.

Authors:  Kawin Leelawat; Taweesak Thongtawee; Siriluck Narong; Somboon Subwongcharoen; Sa-ad Treepongkaruna
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

8.  MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.

Authors:  Weidong Lu; Zhen Xu; Min Zhang; Yun Zuo
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 9.  Role of tumor-associated macrophages in the progression of hepatocellular carcinoma.

Authors:  Ken Shirabe; Yohei Mano; Jun Muto; Rumi Matono; Takashi Motomura; Takeo Toshima; Kazuki Takeishi; Hidekaki Uchiyama; Tomoharu Yoshizumi; Akinobu Taketomi; Masaru Morita; Shunichi Tsujitani; Yoshihisa Sakaguchi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-11-25       Impact factor: 2.549

Review 10.  Cancer-associated fibroblasts in hepatocellular carcinoma.

Authors:  Norio Kubo; Kenichiro Araki; Hiroyuki Kuwano; Ken Shirabe
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.